Gene therapy for global health: A Q&A with Dr. Mike McCune
Dr. Mike McCune, head of the foundation’s HIV Frontiers Program, details a groundbreaking new partnership with Novartis to develop affordable, single-dose gene therapies for people infected with sickle cell disease and HIV.
The time to adapt to climate change is now
CEO Mark Suzman makes the case for immediate global action on climate change, including investments in research and innovation and stronger social safety nets.
Helping farmers adapt to the new normal: A Q&A with Rodger Voorhies
Rodger Voorhies, president of the foundation’s Global Growth & Opportunity Division, discusses efforts to help farmers adapt to climate change in countries that are already being affected by rising temperatures.
Sign up for The Optimist newsletter
Subscribe to The Optimist to get weekly updates on the latest in global health, gender equality, education, and more.